TLR2 and myeloid sarcoma: In neuroinflammatory models, TLR2, TLR9, MyD88, and IRF‐3 deficiency resulted in protective effects, whereas TLR4, TLR2, and TRIF deficiency resulted in aggravating disease, indicating the complex role of TLRs in inflammatory development in MS.56, 57, 58, 59, 60, 61